Why Eli Lilly Is Buying Centessa for $7.8 Billion
✨ AI Summary
🔊 جاري الاستماع
Bloomberg Intelligence's Sam Fazeli discusses Eli Lilly's $7.8 billion acquisition of Centessa, marking the company's entry into the sleep disorder drug market. He speaks on "Bloomberg Open Interest." (Source: Bloomberg)